Zoledronic Acid for the Prevention of Bone Loss in Postmenopausal Women With Low Bone Mass

2009 ◽  
Vol 114 (5) ◽  
pp. 999-1007 ◽  
Author(s):  
Michael McClung ◽  
Paul Miller ◽  
Chris Recknor ◽  
Peter Mesenbrink ◽  
Christina Bucci-Rechtweg ◽  
...  
Keyword(s):  
Zoledronic Acid ◽  
Bone Loss ◽  
Bone Mass ◽  
Postmenopausal Women ◽  
Low Bone Mass ◽  
Prevention Of Bone Loss

scholarly journals Sclareol prevents ovariectomy-induced bone loss in vivo and inhibits osteoclastogenesis in vitro via suppressing NF-κB and MAPK/ERK signaling pathways

2019 ◽  
Vol 10 (10) ◽  
pp. 6556-6567 ◽  
Author(s):  
Haiming Jin ◽  
Zhenxuan Shao ◽  
Qingqing Wang ◽  
Jiansen Miao ◽  
Xueqin Bai ◽  
...  
Keyword(s):  
Bone Loss ◽  
Bone Mass ◽  
Postmenopausal Women ◽  
Postmenopausal Osteoporosis ◽  
Bone Quality ◽  
Progressive Disease ◽  
Erk Signaling ◽  
Low Bone Mass

Postmenopausal osteoporosis (PMO) is a progressive disease occurring in elderly postmenopausal women that is characterized by low bone mass and impaired bone quality.

Circulating activin-A is elevated in postmenopausal women with low bone mass: the three-month effect of zoledronic acid treatment

2012 ◽  
Vol 24 (7) ◽  
pp. 2127-2132 ◽  
Author(s):  
A. D. Anastasilakis ◽  
S. A. Polyzos ◽  
P. Makras ◽  
A. Gkiomisi ◽  
M. Savvides ◽  
...  
Keyword(s):  
Zoledronic Acid ◽  
Bone Mass ◽  
Postmenopausal Women ◽  
Acid Treatment ◽  
Activin A ◽  
Low Bone Mass

Ipriflavone prevents radial bone loss in postmenopausal women with low bone mass over 2 years

1997 ◽  
Vol 7 (2) ◽  
pp. 119-125 ◽  
Author(s):  
S. Adami ◽  
L. Bufalino ◽  
R. Cervetti ◽  
C. Di Marco ◽  
O. Di Munno ◽  
...  
Keyword(s):  
Bone Loss ◽  
Bone Mass ◽  
Postmenopausal Women ◽  
Low Bone Mass ◽  
Radial Bone

scholarly journals Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC

2009 ◽  
Vol 117 (3) ◽  
pp. 603-609 ◽  
Author(s):  
Stephanie L. Hines ◽  
Betty Mincey ◽  
Todor Dentchev ◽  
Jeff A. Sloan ◽  
Edith A. Perez ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Zoledronic Acid ◽  
Bone Loss ◽  
Postmenopausal Women ◽  
Prevention Of Bone Loss

Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment

2014 ◽  
Vol 19 (3) ◽  
pp. 299-306 ◽  
Author(s):  
Athanasios D Anastasilakis ◽  
Stergios A Polyzos ◽  
Polyzois Makras ◽  
Athina Gkiomisi ◽  
Grigorios Sakellariou ◽  
...  
Keyword(s):  
Zoledronic Acid ◽  
Bone Mass ◽  
Postmenopausal Women ◽  
Low Bone Mass ◽  
Semaphorin 4D ◽  
Teriparatide Treatment

Risedronate Reverses Bone Loss in Postmenopausal Women With Low Bone Mass: Results From a Multinational, Double-Blind, Placebo-Controlled Trial

2000 ◽  
Vol 55 (10) ◽  
pp. 630-632
Author(s):  
Ignac Fogelman ◽  
Claude Ribot ◽  
Roger Smith ◽  
Dominique Ethgen ◽  
Earl Sod ◽  
...  
Keyword(s):  
Bone Loss ◽  
Bone Mass ◽  
Postmenopausal Women ◽  
Controlled Trial ◽  
Low Bone Mass ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document